Changhee Park

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Venues

Nature communications

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

Molecular cancer therapeutics

Seoul National University Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Seoul National University Hospital Mar 01 2016

South Korea

Resident :: Internal Medicine

Publications

Changhee Park, Ho Sup Lee, Byung Soo Kim, Won-Sik Lee, Young Rok Do, Jae-Yong Kwak, Ho-Jin Shin, Sung-Yong Kim, Jun Ho Yi, Sung-Nam Lim, Jeong-Ok Lee, Deok Hwan Yang, Hun Jang, Byoungsan Choi, Jiwoo Lim, Choong Hyun Sun, Ja Min Byun, Sung Soo Yoon, Youngil Koh
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial. Nature communications 15 (1) (2024)
Changhee Park, Ho Sup Lee, Byung Soo Kim, Won-Sik Lee, Young Rok Do, Jae-Yong Kwak, Ho-Jin Shin, Sung-Yong Kim, Jun Ho Yi, Sung-Nam Lim, Jeong-Ok Lee, Deok Hwan Yang, Hun Jang, Byoungsan Choi, Jiwoo Lim, Choong Hyun Sun, Ja Min Byun, Sung Soo Yoon, Youngil Koh
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial. Nature communications 15 (1) (2024)
Changhee Park, Ho Sup Lee, Byung Soo Kim, Won-Sik Lee, Young Rok Do, Jae-Yong Kwak, Ho-Jin Shin, Sung-Yong Kim, Jun Ho Yi, Sung-Nam Lim, Jeong-Ok Lee, Deok Hwan Yang, Hun Jang, Byoungsan Choi, Jiwoo Lim, Choong Hyun Sun, Ja Min Byun, Sung Soo Yoon, Youngil Koh
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial. Nature communications 15 (1) (2024)
Hyojin Kim, Seokhwi Kim, Sangjoon Choi, Changhee Park, Seonwook Park, Sergio Pereira, Minuk Ma, Donggeun Yoo, Kyunghyun Paeng, Wonkyung Jung, Sehhoon Park, Chan-Young Ock, Se-Hoon Lee, Yoon-La Choi, Jin-Haeng Chung
Clinical Validation of Artificial Intelligence-Powered PD-L1 Tumor Proportion Score Interpretation for Immune Checkpoint Inhibitor Response Prediction in Non-Small Cell Lung Cancer. JCO precision oncology 8 (2024)
Jin-Hee Ahn, Jeeyun Lee, Changhee Park, Seung-Hoon Beom, Seung Hyun Kim, Young Han Lee, Kum-Hee Yun, Jeong Eun Kim, Woo-Yeol Baek, Yoon Dae Han, Sang-Kyum Kim, Hyang Joo Ryu, Inkyung Jung, JooHee Lee, Hong In Yoon, Hyo Song Kim
Clinical Activity of TGF-β Inhibitor Vactosertib in Combination with Imatinib in Desmoid Tumors: A Multicenter Phase Ib/II Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Changhee Park, Ho Sup Lee, Byung Soo Kim, Won-Sik Lee, Young Rok Do, Jae-Yong Kwak, Ho-Jin Shin, Sung-Yong Kim, Jun Ho Yi, Sung-Nam Lim, Jeong-Ok Lee, Deok Hwan Yang, Hun Jang, Byoungsan Choi, Jiwoo Lim, Choong Hyun Sun, Ja Min Byun, Sung Soo Yoon, Youngil Koh
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial. Nature communications 15 (1) (2024)
Jin-Hee Ahn, Jeeyun Lee, Changhee Park, Seung-Hoon Beom, Seung Hyun Kim, Young Han Lee, Kum-Hee Yun, Jeong Eun Kim, Woo-Yeol Baek, Yoon Dae Han, Sang-Kyum Kim, Hyang Joo Ryu, Inkyung Jung, JooHee Lee, Hong In Yoon, Hyo Song Kim
Clinical Activity of TGF-β Inhibitor Vactosertib in Combination with Imatinib in Desmoid Tumors: A Multicenter Phase Ib/II Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Jin-Hee Ahn, Jeeyun Lee, Changhee Park, Seung-Hoon Beom, Seung Hyun Kim, Young Han Lee, Kum-Hee Yun, Jeong Eun Kim, Woo-Yeol Baek, Yoon Dae Han, Sang-Kyum Kim, Hyang Joo Ryu, Inkyung Jung, JooHee Lee, Hong In Yoon, Hyo Song Kim
Clinical activity of transforming growth factor-β inhibitor vactosertib in combination with imatinib in desmoid tumors: a multicenter phase Ib/II study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Hyojin Kim, Seokhwi Kim, Sangjoon Choi, Changhee Park, Seonwook Park, Sergio Pereira, Minuk Ma, Donggeun Yoo, Kyunghyun Paeng, Wonkyung Jung, Sehhoon Park, Chan-Young Ock, Se-Hoon Lee, Yoon-La Choi, Jin-Haeng Chung
Clinical Validation of Artificial Intelligence-Powered PD-L1 Tumor Proportion Score Interpretation for Immune Checkpoint Inhibitor Response Prediction in Non-Small Cell Lung Cancer. JCO precision oncology 8 (2024)
Changhee Park, Bhumsuk Keam, Soon Ho Yoon, Chan-Young Ock, Sun Mi Choi, Miso Kim, Young Sik Park, Tae Min Kim, Do-Youn Oh, Dong-Wan Kim, Young Whan Kim, Dae Seog Heo, Yung-Jue Bang
Clinical insights on outcomes of corticosteroid administration in immune checkpoint inhibitor-induced pneumonitis by retrospective case series analysis. ESMO open 4 (6) (2019)
Changhee Park, Tae Min Kim, Chan-Young Ock, Bhumsuk Keam, Dong Wan Kim, Dae Seog Heo
Clinical Application of Next-Generation Sequencing-Based Panel to BRAF Wild-Type Advanced Melanoma Identifies Key Oncogenic Alterations and Therapeutic Strategies. Molecular cancer therapeutics 19 (3) (2019)

Changhee Park.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Changhee Park